Physician profile
Patrick Scanlon
NPI 1356440234
$10,046.04
in general payments reported to CMS, 2019-2025
43 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $311 · 2021: $1,101 · 2022: $4,706 · 2023: $1,207 · 2024: $945 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,215.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,720.00 | 2019-2025 | |
| Medtronic, INC. | $1,316.34 | 2022-2025 | Symbotex, Interstim, Signia |
| Davol INC. | $1,055.64 | 2020-2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $639.41 | 2021-2025 | Gattex |
| Abbvie INC. | $628.17 | 2021-2025 | Dalvance, Strattice Reconstructive Tissue Matrix Bps |
| Myriad Genetic Laboratories, INC. | $385.75 | 2020-2025 | Myrisk |
| Allergan, INC. | $330.55 | 2019-2022 | |
| Boston Scientific Corporation | $165.08 | 2019-2022 | |
| Tela Bio, INC. | $148.77 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Hologic Sales and Service, LLC | $139.06 | 2023-2025 | Coolseal Generator, Localizer, Trunode |
| Ethicon US, LLC | $129.29 | 2021-2025 | Linx Reflux Management System, Harmonic |
| Amgen INC. | $125.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $104.52 | 2024-2025 | |
| Csl Behring | $100.91 | 2019-2021 | |
| Heron Therapeutics, INC. | $95.69 | 2021-2024 | Zynrelef |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $76.52 | 2022-2024 | Bridion, Keytruda, Lynparza |
| Integra Lifesciences Corporation | $74.91 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Shire North American Group INC | $65.91 | 2019 | |
| Innovation Technologies INC | $64.33 | 2024-2025 | Irrisept |
| Baxter Healthcare | $55.81 | 2021-2022 | |
| Hydrofera LLC | $53.28 | 2025 | Hydrofera Blue |
| Organogenesis INC. | $50.80 | 2023-2024 | Puraply |
| Conmed Corporation | $48.28 | 2023-2024 | Airseal, Conmed Trocars |
| Biotissue Holdings INC. | $46.56 | 2023 | |
| Innocoll Pharmaceuticals Limited | $40.88 | 2021-2022 | |
| Smith+Nephew, INC. | $37.50 | 2025 | Collagenase Santyl |
| Trevena, INC. | $35.72 | 2021-2022 | |
| Sanara Medtech INC. | $34.27 | 2022-2023 | Celleraterx |
| Lucid Diagnostics INC. | $32.30 | 2024 | |
| Carl Zeiss Meditec, INC. | $32.22 | 2019 | |
| Tetraphase Pharmaceuticals, INC. | $30.46 | 2020 | |
| Pfizer INC. | $23.41 | 2024 | |
| Enterra Medical, INC. | $18.79 | 2022 | |
| Misonix INC | $16.04 | 2020 | |
| Hologic INC | $14.92 | 2022 | |
| Medtronic USA, INC. | $14.70 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.46 | 2022 | |
| Zimmer Biomet Holdings, INC. | $14.02 | 2024 | Ribfix Blu Advantage |
| Coopersurgical, INC. | $13.57 | 2025 | Onetrac Lx |
| Bard Peripheral Vascular, INC. | $13.52 | 2021 | |
| Somavac Medical Solutions, INC. | $13.10 | 2021 | |
| Kci USA, INC. | $12.84 | 2022 | |
| Convatec INC. | $12.74 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Scanlon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.